Tumor cell lysates (TCLs) are a good immunogenic source of tumor-associated antigens.
Since whole necrotic TCLs can enhance the maturation and antigen-presenting ability of …

For the successful development of various cellular products in cancer immunotherapy, an
effective ex vivo priming technique for immune cells is often required. Among a variety of …

Cancer is the leading cause of mortality worldwide, which necessitates our consideration
related to novel treatment approach. Tumor cells at the tumor microenvironment (TME) …

The advancements in immuno-oncology have created a new and unparalleled opportunity
for the advancement of vaccination methods. Therapeutic DNA cancer vaccines are now …